Screener
ADMA Biologics ADMA Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from ADMA Biologics’s reported figures.
Based on trailing twelve months.
The source filing: ADMA Biologics’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 5:16 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001140361-26-031445
FAQ
- What is ADMA Biologics's asset turnover?
- ADMA Biologics (ADMA) reported asset turnover of 0.8× in Q2 2026.
- How has ADMA Biologics's asset turnover changed year-over-year?
- ADMA Biologics's asset turnover decreased by 18.7% year-over-year, from 1× to 0.8×.
- What is the long-term trend for ADMA Biologics's asset turnover?
- Over 5 years (2020 to 2025), ADMA Biologics's asset turnover has grown at a 29.5% compound annual growth rate (CAGR), from 0.3× to 0.9×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.
Ask your AI about ADMA Biologics's asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude